Contact this trialFirst, we need to learn more about you.
AP1189 + Methotrexate for Rheumatoid Arthritis
Recruiting0 awardsPhase 2
Duncansville, Pennsylvania
This trial is testing a new drug called AP1189 in combination with methotrexate for people with early rheumatoid arthritis. Participants will be given different doses of AP1189 for 12
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service